Amkay Products IPO: Issue subscribed over 32 times on day 1, check subscription status, GMP, and other details
Amkay Products IPO: From price band to GMP - here's everything you need to know In the fiscal years ending December 31 of 2021, 2022, and 2023, the revenue generated from manufacturing operations was ₹3,020.24 lakh, ₹2,255.89 lakh, and ₹2,224.59 lakh, respectively. Concurrently, revenue from branding and trading operations for the same periods stood at ₹1049.71 lakh, ₹1394.48 lakh, ₹561.83 lakh, and ₹437.71 lakh, respectively. The Amkay Products IPO was subscribed over 32.61 times on the first day of subscription.
The retail category, which was subscribed 54.15 times, received 4,12,58,000 shares against offered 7,62,000 applications. Meanwhile, the QIB portion received a tepid response, and was subscribed 0.6 times. The QIB category received 24,000 applications against offered 4,34,000 shares offered.
On the other hand, Non Institutional Investors (NII) received 1,22,58,000 shares against offered 4,46,000 shares. The NII portion was subscribed 27.48 times on the first day of bidding. Also read: General Atlantic-backed TBO Tek IPO opens next week.
GMP, price, size, review, other details of upcoming IPO The SME IPO intends to raise more than ₹12.61 crore through a fresh issue of 22.92 lakh shares. The healthcare manufacturer has established the price range for its upcoming IPO between ₹52 and ₹55 per share. Investors can bid for a minimum of 2,000 shares and in multiples thereafter.
Hem Securities Limited is the book running lead manager for the Amkay Products IPO, while Bigshare Services Pvt Ltd has been appointed as the registrar for the offering. Hem Finlease has been assigned the role of market maker for the Amkay Products IPO. The allotment for the Amkay Products IPO is expected to be finalized on Monday, May 6, 2024.
. Read more on livemint.com
